Dr Trudy Smith addresses the needs of younger cervical cancer survivors when managing menopause.

Menopause is a natural phase of life for most women, typically occurring between the ages of 45 and 55. However, for women treated for cervical cancer, particularly those who receive radiation, chemotherapy, or surgical removal of the ovaries, menopause can occur much earlier and more abruptly. 

One such patient, in her early 40s, found herself facing premature menopause after undergoing treatment. Her experience highlights a growing concern among younger cancer survivors: the lack of adequate support and tailored guidance for women navigating early treatment-induced menopause.

Premature menopause after cervical cancer treatment

Cervical cancer treatment often involves interventions that affect the reproductive system. Radiation to the pelvic area, oophorectomy (surgical removal of the ovaries), and certain chemotherapies can all lead to ovarian failure and subsequent menopause. 

This process, unlike natural menopause, can be sudden and intense, with symptoms manifesting overnight rather than gradually over several years.

The patient described experiencing classic menopausal symptoms: hot flashes, night sweats, vaginal dryness, mood swings, and fatigue. However, what compounded her distress was the emotional and psychological impact. She wasn’t prepared for such a life-altering transition, especially so early. “I felt like I’d aged overnight,” she said. “And yet, when I sought support, I found myself in rooms full of women who were a generation older. I couldn’t relate to their experiences, and they couldn’t relate to mine.”

The gap in support for younger women

This disconnect underscores a significant gap in post-cancer care. While support groups for menopausal women are increasingly common, they often cater to those going through menopause naturally. The emotional journey, priorities, and life circumstances of a woman in her 40s, especially one dealing with the aftermath of cancer, are markedly different from those of someone in her 50s or 60s experiencing menopause as a part of natural aging.

Younger women may also face challenges, such as infertility, relationship strain, loss of sexual function, and the pressure of managing family and career at a time when they expected to be in their prime. For many, this premature transition carries a sense of grief and identity loss that is often overlooked in mainstream support systems.

A multi-disciplinary approach to management

Managing premature menopause in cervical cancer survivors requires a multi-disciplinary approach. Oncologists, gynaecologists, endocrinologists, mental health professionals, and primary care physicians should work collaboratively to provide comprehensive care tailored to the patient’s unique needs.

Hormone replacement therapy (HRT) is often a first-line option for managing menopausal symptoms in women who are not contraindicated due to their cancer type. 

For women with cervical cancer, HRT is generally considered safe unless there are other complicating factors. 

In this patient’s case, careful consultation with her oncology and gynaecology team allowed her to begin HRT, which significantly improved her quality of life. She may require both oral or transdermal hormone treatment as well as vaginal oestrogen to improve lubrication to decrease bladder infections and improve intercourse.

Non-hormonal treatments also play a role. Antidepressants, lifestyle changes, cognitive behavioural therapy (CBT), and dietary supplements can help manage symptoms. Vaginal moisturisers and lubricants can alleviate genitourinary symptoms, improving comfort and sexual health.

Psychological and emotional support

Emotional support is as critical as medical treatment. Younger women undergoing premature menopause often struggle with feelings of isolation, anxiety, and depression. 

Psychotherapy, peer support groups, and survivor networks that specifically cater to younger women with cancer-induced menopause are essential but sadly lacking in SA.

A call for awareness and resources

This patient’s experience isn’t unique, and her voice echoes the needs of many women who face the dual challenge of surviving cancer and managing its long-term consequences. Healthcare providers must proactively address menopause during survivorship care planning, offering information, resources, and referrals early in the process.

In conclusion, premature menopause following cervical cancer treatment is a profound and often under-supported experience for younger women. This can be adequately managed with hormone replacement therapy as cervical cancer is not a hormone-dependant tumour. 

Through improved awareness, dedicated support systems, and individualised care, the medical community can better address this critical aspect of cancer survivorship for younger cervical cancer survivors.

MEET THE EXPERT

Dr Trudy Smith is a gynaecology oncologist at Wits Donald Gordon Medical Centre and a senior lecturer at the University of Witwatersrand. She has a keen interest in teaching postgraduates and undergraduates.

Header image by Freepik